Displaying 1 to 7 of 7 investments
Country Date Notes
Achillion Pharmaceuticals Inc
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
United States N/A
Initial investment. Round participant. Active
Achillion Pharmaceuticals Inc
Biopharmaceutical company dedicated to bringing important new treatments to patients with infectious disease.
United States N/A
Initial investment. Round participant. Active
Arresto BioSciences Inc
A biotechnology company, develops medicines to treat cancer and fibrotic diseases
United States 20 Dec 2010 Acquisition
USD 225,000,000 (USD 225,000,000) deal size. Active
Calistoga Pharmaceuticals Inc
Biopharmaceutical company dedicated to developing targeted therapies to improve the health of patients with cancer or inflammatory diseases.
United States 1 Apr 2011 Acquisition
Active
CGI Pharmaceuticals Inc
A biopharmaceutical company developing small molecule therapeutics for multiple oncology and immunology-based indications.
United States 8 Jul 2010 Acquisition
USD 120,000,000 (USD 120,000,000) deal size.
Corus Pharma Inc
A specialty pharmaceutical development company developing and obtaining regulatory approvals of products for respiratory and infectious diseases.
United States 1 Aug 2006 Acquisition
USD 365,000,000 (USD 365,000,000) deal size.
Triangle Pharmaceuticals Inc
Anti-viral and oncology licensing company.
United States 4 Dec 2002 Acquisition
USD 464,000,000 (USD 464,000,000) deal size.